AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase

Evidence-based Complementary and Alternative Medicine

Volumn 7, Issue 1, 2010, Pages 63-68

  Hattori, Noriko ^a,b   Nomoto, Hiroshi ^a   Fukumitsu, Hidefumi ^a   Mishima, Satoshi ^b   Furukawa, Shoei ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Api Company Ltd   (Japan)

Author keywords

5 bromodeoxy uridine; Adenosine A2A receptor; Neuronal differentiation; Neurotrophic factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE DERIVATIVE; ADENOSINE MONOPHOSPHATE N1 OXIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; ROYAL JELLY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 77249132249     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem146     Document Type: Article

References (31)

1. Oka H, Emori Y, Kobayashi N, Hayashi Y, Nomoto K. Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses. Int Immunopharmacol 2001;1:521-532
2. Taniguchi Y, Kohno K, Inoue S, Koya-Miyata S, Okamoto I, Arai N, et al. Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 2003;3:1313-1324
3. Hidaka S, Okamoto Y, Uchiyama S, Nakatsuma A, Hashimoto K, Ohnishi T, et al. Royal Jelly Prevents Osteoporosis in Rats: beneficial effects in ovariectomy model and in bone tissue culture model. Evid Based Conmplement Alternat Med 2006;3:339-348
4. Suzuki K, Isohama Y, Maruyama H, Yamada Y, Narita Y, Ohta S, et al. Estrogenic activities of fatty acids and a sterol isolated from royal jelly. Evid Based Complement Alternat Med 2007; in press.
5. Hattori N, Nomoto H, Mishima S, Inagaki S, Goto M, Sako M, et al. Identification of AMP N1-oxide in royal jelly as a neurotrophic component for cultured rat pheochromocytoma PC12 cells. Biosci Biotechnol Biochem 2006;70:897-906.
6. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976;73:2424-2428
7. Greene LA, Kaplan DR. Early events in neurotrophin signaling via Trk and p75 receptors. Curr Opin Neurobiol 1995;5:579-587
8. Charles MP, Adamski D, Kholler B, Pelletier L, Berger F, Wion D. Induction of neurite outgrowth in PC12 cells by the bacterial nucleoside N6-methyldeoxyadenosine is mediated through adenosine A2A receptors and via cAMP and MAPK signaling pathways. Biochem Biophys Res Commun 2003;304:795-800.
9. Sanchez S, Jimenez C, Carrera AC, Diaz-Nido J, Avila J, Wandosell F. A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation. Neurochem Int 2004;44:231-242
10. Piiper A, Dikic MP, Lutz J, Leser B, Kronenberger R, Elez H, et al. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. J Biol Chem 2002;277:43623-43630
11. Cheng HC, Shih HM, Chern Y. Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade. J Biol Chem 2002;277:33930-33942
12. Furukawa S, Kamo I, Furukawa Y, Akazawa S, Sotoyoshi E, Itoh K, et al. A highly sensitive enzyme immunoassay for mouse beta nerve growth factor. J Neurochem 1983;40:734-744
13. Cheng Y, Zhizhin I, Perlman RL, Mangoura D. Prolactin-induced cell proliferation in PC12 cells depends on JNK but not ERK activation. J Biol Chem 2000;275:23326-23332
14. Richter-Landsberg C, Jastorff B. The role of cAMP in nerve growth factor-promoted neurite outgrowth in PC12 cells. J Cell Biol 1986;102:821-829
15. Rao YP, Buckley DJ, Buckley AR. Rapid activation of mitogenactivated protein kinase and p21 rats by prolactin and interleukin 2 in rat Nb2 node lymphoma cells. Cell Growth Differ 1995;6:1235-1244
16. Lee FS, Chao MV. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci USA 2001;98:3555-3560
17. Daval JL, Nehlig A, Nicolas F. Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci 1991;49:1435-1453
18. Weaver DR. A2A adenosine receptor gene expression in developing rat brain. Brain Res Mol Brain Res 1993;20:313-327
19. Kim HS, Yumkham S, Kim SH, Yea K, Shin YC, Ryu SH, et al. Secretin induces neurite outgrowth of PC12 through cAMP-mitogen-activated protein kinase pathway. Exp Mol Med 2006;38:85-93.
20. Obara Y, Labudda K, Dillon TJ, Stork PJ. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 2004;117:6085-6094
21. Francis H, Glaser S, Ueno Y, Lesage G, Marucci L, Benedetti A, et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic billary epithelium through changes in the PKA/ Src/MEK/ERK1/2 pathway. J Hepatol 2004;41:528-537
22. Walowitz JL, Roth JA. Activation of ERK1 and ERK2 is required for manganese-induced neurite outgrowth in rat pheochromocytoma (PC12) cells. J Neurosci Res 1999;57:847-854
23. Piiper A, Dikic I, Lutz MP, Leser J, Kronenberger B, Elez R, et al. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. J Biol Chem 2002;277:43623-43630
24. Zhang Z, Tarone G, Turner DC. Expression of integrin alpha 1 beta 1 is regulated by nerve growth factor and dexamethasone in PC12 cells. Functional consequences for adhesion and neurite outgrowth. J Biol Chem 1993;268:5557-5565
25. Erhardt JA, Pittman RN. p21WAF1 induces permanent growth arrest and enhances differentiation, but does not alter apoptosis in PC12 cells. Oncogene 1998;16:443-451
26. Sun CN, Cheng HC, Chou JL, Lee SY, Lin YW, Lai HL, et al. Rescue of p53 blockade by A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X. Mol Pharmacol 2006;70:454-466
27. Jones PA, Smith RA, Stone TW. Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience 1998;85:229-237
28. Latini S, Bordoni F, Corradetti R, Pepeu G, Pedata F. Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 1999;128:1035-1044
29. Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pèzzola A, et al. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J Neurosci 2002;22:1967-1975
30. Stone TW. Purines and neuroprotection. Adv Exp Med Biol 2002;513:249-280
31. Cabeza de Vaca S, Kannan P, Pan Y, Liang N, Sun Y, Carr KD. The adenosine A2A receptor agonist, CGS-21680, blocks excessive rearing, acquisition of wheel running, and increases nucleus accumbens CREB phosphorylation in chronically food-restricted rats. Brain Res 2007;1142:100-109